UC Davis Residency Faculty Publications, Posters and Professional Presentations

Pharm.D., BCPS, MCCM, FACCP, FASHP, FCSHP

Gosselin RC, Francart SJ, Hawes EM, Moll S, Dager WE, Adcock DM.
Heparin-Calibrated Chromogenic Anti-Xa Activity Measurements in Patients
Receiving Rivaroxaban: Can This Test Be Used to Quantify Drug Level? Ann
Pharmacother. 2015;49:777-83

Dager W, Tsu L, Pon T. Considerations for Systemic Anticoagulation in ESRD. Semin Dial. 2015;28:354-62.

Dager W, Hellwig T. Current knowledge about measuring the anticoagulant effect and managing bleeding with direct oral anticoagulants. Am J Health Syst Pharm Am J Health Syst
Pharm. 2016 ;73(10 Suppl 2):S14-26.

Chen LD, Roberts AJ, Dager WE. Safety and efficacy of starting warfarin after
two consecutive platelet count rises in heparin-induced thrombocytopenia. Thromb
Res. 2016;144:229-33.

Dager WE, Lee JA. Filtering Out Use of DOACs in Hemodialysis. Ann
Pharmacother. 2017;51:511-513.

Van Cott EM, Roberts AJ, Dager WE. Laboratory Monitoring of Parenteral Direct
Thrombin Inhibitors. Semin Thromb Hemost. 2017;43:270-276.

Dager W, Banares L. Reversing the anticoagulation effects of dabigatran. Hosp
Pract (1995). 2017;45:29-38.

Bain J, Flannery AH; Flynn J, Dager W. Heparin Induced Thrombocytopenia with Mechanical Circulatory Support Devices – Review of the Literature and Management Considerations. J Thromb Thrombolysis. 2017;44:76-87.

Van Cott EM, Roberts AJ, Dager WE. Response to: "More on the Limitations of the aPTT for Monitoring Argatroban Therapy". Semin Thromb Hemost. 2017;43:644.

Walker EA, Dager WE. Bridging with Tirofiban during Oral Antiplatelet Interruption: A Single-Center Case Series Analysis Including Patients on Hemodialysis. Pharmacotherapy. 2017;37:888-892.

Dager WE, Banares L. Reversing the anticoagulation effects of dabigatran. Hosp Pract (1995). 2017;45:29-38.

Steele AP, Lee JA, Dager WE. Incomplete dabigatran reversal with idarucizumab. Clin Toxicol (Phila). 2018;56:216-218.

Walker EA, Roberts AJ, Louie EL, Dager WE. Bivalirudin Dosing Requirements in Adult Patients on Extracorporeal Life Support with or without Continuous Renal Replacement Therapy. ASAIO, 2018.

Dager WE, Roberts AJ, Nishijima DK. Effect of low and moderate dose FEIBA to
reverse major bleeding in patients on direct oral anticoagulants. Thromb Res.
2018;173:71-76.

Hoff BM, Maker JH, Dager WE, Heintz BH. Antibiotic Dosing for Critically Ill
Adult Patients Receiving Intermittent Hemodialysis, Prolonged Intermittent Renal
Replacement Therapy, and Continuous Renal Replacement Therapy: An Update. Ann
Pharmacother. 2019.

Dager WE, Ansell J, Barnes GD, Burnett A, Deitelzweig S, Minichiello T,
Triller D, Kaatz S. Reduce the Likelihood of Patient Harm Associated with the
Use of Anticoagulant Therapy: Commentary from the Anticoagulation Forum on the
Updated Joint Commission NPSG.03.05.01 Elements of Performance. Jt Comm J Qual
Patient Saf. 2020;46:173-180.

TEXTBOOK CHAPTERS - 26 Textbook Chapters

“How I manage excessive anticoagulation” Society of Critical Care Medicine 42nd Critical Care Congress, Phoenix, AZ January 17th, 2015

“Pharmacotherapy considerations in acute kidney injury” Society of Critical Care Medicine 42nd Critical Care Congress, Phoenix, AZ January 19th, 2015

“HIT in the grey zone, how I manage the patients with an uncertain diagnosis” Society of Critical Care Medicine 42nd Critical Care Congress, Phoenix, AZ January 21st, 2015

“Exploring the management of patients receiving new oral anticoagulants” Sharp Healthcare Grand Rounds, San Diego Ca February 26th, 2015

“Wrangling and Taming Anticoagulation Therapy” Wyoming Pharmacist Association, Cody, WY June 12th, 2015

“Tranexamic acid and prothrombin complex concentrates for traumatic hemorrhage: PRO” American College of Clinical Pharmacy Annual Meeting, San Francisco. CA October 19th, 2015

“Evaluation and appropriate use of new direct oral anticoagulant agents: Reversal” American Society of Health System Pharmacists Mid-Year Clinical Meeting, New Orleans, LA December 7th, 2015

“Managing Excessive Anticoagulation in the Acutely Ill” American Society of Health System Pharmacists Mid-Year Clinical Meeting, New Orleans, LA December 8th, 2015

“Recognizing Acquired Hemophilia A in the patient with unexplained bleeding” American Society of Health System Pharmacists Mid-Year Clinical Meeting, New Orleans, LA December 8th, 2015

“Anticoagulation Jeopardy” – Invited panelist – Society of Critical Care Medicine Congress, Orlando, FL, February 24, 2016

“DOAC’s and their Reversal: The Slippery Slope” 6th Annual Cardiovascular Nurse/Technologist Symposium, Sacramento, CA, May 7th, 2016

“Exploring your Carrier Pharmacy” Sacramento State University Future Pharmacist Club. March 30th, 2016

“NOACS and their Reversal” 6th Annual Cardiovascular Nurse/Technologist Symposium, Sacramento, CA May 7th, 2016

“Optimizing AC therapy in the acute care setting: Considerations for success” Washington State Hospital Association” June 6th, 2016

“Anti-Coagulation Update Practical Tips” California North State College of Pharmacy Preceptor Conference” Elk Grove, CA, June 17th, 2016.

“Intra Cranial Hemorrhage” Pharmacy Invitational Conference on Antithrombosis Therapy, Las Vegas, NV, December 5th, 2016.

“Direct Oral Anticoagulants: Drug Therapy Management and Reversal” American Society of Health System Pharmacists Mid-Year Clinical Meeting, Las Vegas, NV December 8th, 2016

“The Direct Acting Oral Anticoagulants (DOACS)” Society of Critical Care Medicine Congress, Honolulu, HI, January 22, 2017.

“Sitting in a River of Blood without a Paddle: Pharmacologic Considerations in Hemorrhagic Shock” Society of Critical Care Medicine Congress, Honolulu, HI, January 24, 2017.

“Anticoagulation considerations in the acute care setting” Anticoagulation Forum, Los Angeles, CA, April 22nd, 2017

“Meet the Experts RoundTable” Anticoagulation Forum April 22, 2017

“Making a difference: From single patient bedside to international aspects of management” Visiting Chinese Professors – University of California, Davis October 10th, 2017

“Reversing Oral Anticoagulants” Adult Current Concepts Course – SCCM San Antonio Feb 26th, 2018

“Reversing Antiplatelet Agents” Society of Critical Care Medicine Congress, San Antonio, Tx February 26th, 2018

“Direct Oral Anticoagulants and Considerations in CKD and AKI” American Society of Nephrology, San Diego, Ca October 24th, 2018

“DOAC level in the case of a major bleed” Pharmacy Invitational Conference on Antithrombosis Therapy, Anaheim, CA, December 1st, 2018.

“Peri-Procedural Anticoagulation” Pharmacy Invitational Conference on Antithrombosis Therapy, Anaheim, CA, December 1st, 2018.

“Current Reversal and Treatment Strategies for DOAC related bleeding” American Society of Health System Pharmacists Mid-Year Clinical Meeting, Anaheim, CA December 3rd, 2018

“Individualizing Anticoagulation in the Acutely Ill: A Case-based Approach” American Society of Health System Pharmacists Mid-Year Clinical Meeting, Anaheim, CA December 4th, 2018

“Building a DOAC reversal management plan – What do I need to know” American Society of Health System Pharmacists Mid-Year Clinical Meeting, Anaheim, CA December 4th, 2018

“The Role of the Health-System Pharmacist in Safely and Effectively Treating Direct Oral Anticoagulant Bleeding with Novel Reversal Agents” Minnesota Society of Health System Pharmacists – Rochester, Minn, Aug 28th, 2019

“Special populations and Transitions of Care” Anticoagulation Forum Boot Camp – Southern Hospitalist Society Meeting, New Orleans, LA, October 2nd, 2019

“Introduction/Skills for Initiating and individualizing Therapy/Case presentation” American Collage of Clinical Pharmacy Annual Meeting, New York, NY, October 28th, 2019

“Exploring Special Populations for cardiovascular Medications in Critically Ill” American Collage of Clinical Pharmacy Annual Meeting, New York, NY, October 28th, 2019

“Skills for revising therapies and adapting to advances in technology” American Collage of Clinical Pharmacy Annual Meeting, New York, NY, October 28th, 2019

“Reversing Anticoagulant and Antiplatelet agents” American Collage of Clinical Pharmacy Annual Meeting, New York, NY, October 28th, 2019

“Direct Oral Anticoagulants for Heparin Induced Thrombocytopenia Management” Pharmacy Invitational Conference on Antithrombosis Therapy, Las Vegas, NV, December 7th, 2019.

“Debate Moderator – Andexanet versus PCC for reversal of oral anti-Xa direct oral anticoagulants” Pharmacy Invitational Conference on Antithrombosis Therapy, Las Vegas, NV, December 7th, 2019.

“Managing HIT in the Critically Ill: Guidelines with Individualization. American Society of Health System Pharmacists Mid-Year Clinical Meeting, Las Vegas, NV, December 11th, 2019.
“Updates in the use of Direct Oral Anticoagulants in Special Populations” American Society of Health System Pharmacists Mid-Year Clinical Meeting, Las Vegas, NV, December 12th, 2019.

“Antibiotic Monitoring: Patient and Clinician Perspectives” Society of Critical Care Medicine Congress 2020, Orlando, FL, February 19,2020

TELECONFERENCES

“HIT, A Heparin Paradox” Teleconference series. 2002-2003. Schentag Corp.

“Cardiology Pharmacotherapies” Society of Critical Care Medicine Podcast on the article “Recent advances in Cardiology Pharmacotherapies for the ICU clinician” December 2006.

“The 2008 Joint Commission National Patient Safety Goal (NPSG) 3E on Anticoagulation Therapy: What every pharmacist needs to know” Webconference for American Society of Health System Pharmacists. March 6th, 2008

Institute for Healthcare Improvement Campaign hour on High-Alert Medications – Panelist
March 11, 2008

Warfarin Management Considerations in Hospitalized Patients” National Teleconference for MedAssists June 24th, 2008

Improving Heparin Safety: Clinical, Laboratory and Safety Issues. Webcast for Cardinal Health, July 11th, 2008.

Resolving Complex Issues in the Use of Anticoagulation Therapy for Venous Thromboembolism: Management of Heparin-induced Thrombocytopenia and Bleeding Complications. ASHP Webinar July 10th and July 17th, 2008

“Questions, Dilemmas, and Conundrums - Managing Patients with Unique Needs” In the changing face of anticoagulation therapy: Improving the management of patients at risk for venous thromboembolism. American Society of Health System Pharmacists Mid-Year Clinical Meeting. December 8, 2009, Las Vegas NV (Also listed above as live presentation)

“Ask the Experts Live Webinar: Practice Pearls Amid the Changing Face of Anticoagulant Therapy” ASHP Advantage Webinar – January 21st, 2010

“Atrial Fibrillation and Stroke Prevention: Managing the shifting approach for oral anticoagulation. National Teleconference for MedAssists January 27th, 2011

“Exploring the new oral anticoagulants: Considerations for safe use”. National Teleconference for MedAssists October 28th, 2011

“New Oral Anticoagulants” Teleconference: Amerinet Regional Meetings. September 13th and October 19th, 2012

“Managing Patients with Hemophilia in the Hospital Setting” ASHP Advantage Webinar February 27th, 2013

“Practical Issues in Developing an Oral Anticoagulant Reversal Strategy” ASHP Advantage Webinar March 20th, 2013

“Pharmacologic Strategies for Testing Acutely Ill Patients with Bleeding Disorders: Role of the Pharmacist” ASHP Advantage Webinar, October 29th, 2013

“Clinical Case Scenarios: Recognition and Treatment of Rare Bleeding Disorders in Emergent Situations” ASHP Advantage Webinar, November 7th, 2013

“Preventing Stroke in Atrial Fibrillation: Pharmacist Role in Optimizing Therapy and Ensuring Patient Safety” ASHP Advantage Webinar, July 9th, 2014

“Optimizing Anticoagulation Therapy: Exploring how to make a difference” WSHA Webinar – April 5th, 2016

“Direct Oral Anticoagulants: Drug Therapy Management and Reversal” ASHP Advantage April 26, 2016

“Individualizing Anticoagulation Therapy” ASHP Foundation April 26, 2016; April 20, 2017

“How Can I Achieve & Surpass the National Patient Safety Goals ?
(Part 1)” The Joint Commission supported Teleconference, May 6th, 2019

PharmD, BCPS, BCCCP, FCCM

Book Chapters

Beldowicz BC, Duby JJ, Pigneri D, Cocanour CS. Glycemic Control in Citically Ill Surgery Patients. In: Surgical Critical: A Clinically Oriented Practical Approach. Springer International Publishing. Gewrebestrasse, Switzerland. May 2018.

Duby JJ, Donnelley MA, Tasaka CL, Heintz BH. Vancomycin. Ch 22. In: Murphy JE. Clinical Pharmacokinetics. 6th ed. Bethesda, MD: American Society of Health-System Pharmacists. 2017.

Duby JJ, Donnelley MA. Heintz BH. Clostridium difficile Associated Diarrhea. Chapter 85. In: Katz MD, Matthias KR, Chisholm-Burns MA. Pharmacotherapy Principles and Practice Study Guide: A Case-Based Care Plan Approach. 3rd edition. New York, NY: McGraw-Hill; 2013: 349 - 352.

Matzke GR, Duby JJ. Vancomycin. In: Murphy JE. Clinical Pharmacokinetics. 5th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2011.

Duby JJ, Heintz BH. Clostridium difficile Associated Diarrhea. In: Katz MD, Matthias KR, Chisholm-Burns MA. Pharmacotherapy Principles and Practice Study Guide: A Case-Based Care Plan Approach. New York, NY: McGraw-Hill; 2010: 327 - 329.


Peer-Reviewed Publications

Schomer KJ, Duby JJ; Firestone RL, Louie EL, Sebat CM, Love DM, Cocanour CS, Albertson TE. Effect of Flumazenil on Hypoactive Delirium in the ICU: A Double-Blind, Placebo-Controlled Pilot Study. Critical Care Explorations. 2(3): e0085, March 2020.

Firestone RL, Parker PL, Pandya KA, Wilson MD, Duby JJ. Moderate-Intensity Insulin Therapy Is Associated With Reduced Length of Stay in Critically Ill Patients With Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State. Crit Care Med. 2019 Mar 7.

Hamrick KL, Beyer CA, Lee JA, Cocanour CS, Duby JJ. Multimodal Analgesia and Opioid Use in Critically Ill Trauma Patients. J Am Coll Surg. 2019 Feb 20.

Lee JA, Duby JJ, Cocanour CS. Effect of early and focused benzodiazepine therapy on length of stay in severe alcohol withdrawal syndrome. Clin Toxicol (Phila). 2019 Feb 7:1-4.

Bouajram RH, Sebat CM, Love D, Louie EL, Wilson MD, Duby JJ. Comparison of Self-Reported and Behavioral Pain Assessment Tools in Critically Ill Patients. J Intensive Care Med. 2018; Jan 1.

Ignoffo R, Chan L, Knapp K, Chan E, Ip E, Bandy J, Besinque K, Colbert J, Duby JJ, Galanto JS, Gloudeman M, Havard P, Lackey G, Lozano E, Scott J, Stewart TL. Efficient and effective precepting of pharmacy students in acute and ambulatory care rotations: A Delphi expert panel study. Am J Health Syst Pharm. 2017 Oct 1;74(19):1570-1578.

Schomer KJ, Sebat CM, Adams JY, Duby JJ, Shahlaie K, Louie EL. Dexmedetomidine for Refractory Intracranial Hypertension. J Intensive Care Med. 2017 Jan.

Duby JJ, Heintz SJ, Bajorek SA, Heintz BH, Durbin-Johnson BP, Cocanour CS. Prevalence and Course of Atrial Fibrillation in Critically Ill Trauma Patients. J Intensive Care Med. 2017; Feb;32(2):140-145.

Tasaka CL, Duby JJ, Pandya K, Wilson MD, Hardin KA. Inadequate Sedation During Therapeutic Paralysis: Use of Bispectral Index in Critically Ill Patients. Drugs – Real World Outcomes. 2016 May; 3(2): 201-208.

Murthy MS, Duby JJ, Parker PL, Durbin-Johnson BP, Roach DM, Louie EL. Blood glucose response to rescue dextrose in hypoglycemic, critically ill patients receiving an insulin infusion. Ann Pharmacother. 2015 Aug;49(8):892-6.

Duby JJ, Berry AJ, Ghayyem P, Wilson MD, Cocanour CS. Alcohol withdrawal syndrome in critically ill patients: Protocolized versus non-protocolized management. Journal of Trauma and Acute Care Surgery. 2014 Sep 22. PMID: 25248063.

Pandya PA, Firestone R, Parker P, Duby JJ. Enhancing Quality and Safety in Insulin Therapy: A multi-disciplinary approach to create and validate continuous infusion insulin protocols. American Journal of Medical Quality. 2014; 29: 23S.

Smith CA, Duby JJ, Utter GH, Galante JM, Scherer LA, Schermer CA. Cost-minimization analysis of two fluid products for resuscitation of critically injured trauma patients. American Journal of Health-System Pharmacy. 2014; 71: 470-475. doi:10.2146/ajhp130295.

Evans CH, Duby JJ, Berry AJ, Schermer CR, Cocanour CS. Enteral albuterol decreases the need for chronotropic agents in patients with cervical spinal cord injury-induced bradycardia. Journal of Trauma and Acute Care Surgery. 2014 Feb; 76(2): 297-302.

Donnelley MA, Duby JJ, Cocanour CS. Safety and Efficacy of Fidaxomicin in Patients With Clostridium Difficile Infection. Clinical Medicine Insights: Therapeutics. 2013; 5: 75 – 79.

Nagle EL, Dager WE, Duby JJ, Roberts AJ, Kenny LE, Murthy MS, Pretzlaff RK. Bivalirudin in pediatric patients maintained on extracorporeal life support. Pediatric Critical Care Medicine. 2013 May;14(4):e182-8. doi: 10.1097/PCC.0b013e31827200b6.

Kopp B, Mrsan M, Erstad BL, Duby JJ. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. American Journal of Health-System Pharmacy. 2007; 64: 2483 – 2487.

Duby JJ, Erstad BL, Abarca J, Camamo JM, Huckleberry Y, Bramblett SN. Impact of delayed initiation of erythropoietin in critically ill patients. BMC Hematology. 2007; 7:1.

Patanwala AE, Duby JJ, Waters D, Erstad BL. Opioid Conversion in Acute Care. Annals of Pharmacotherapy. 2007; 41(2): 255 – 266.

Duby JJ, Campbell RK. Treatment of Painful Diabetic Neuropathy. U.S. Pharmacist. 2004; 29(11).

Duby JJ, Campbell RK, Setter SM, White JR, Rasmussen KA. Diabetic Neuropathy: An Intensive Review. American Journal of Health-System Pharmacy. 2004; 61: 160 - 173.


Poster Presentations
Young SR, Duby JJ, Louie, EL, Palmieri T. Impact of Multimodal Analgesia on Critically Ill Burn Patients. 52nd Annual Meeting. American Burn Association. Orlando, FL. March 18, 2020.

Schomer KJ, Duby JJ, Firestone RL, Louie EL, Sebat CM, Cocanour CS, Albertson TA. Flumazenil for hypoactive delirium secondary to benzodiazepine exposure (FLYP Trial). 48th Critical Care Congress. San Diego, CA. Snapshot Theater Presentation. February 19, 2019.

Schomer KJ, Duby JJ, Firestone RL, Louie EL, Sebat CM, Cocanour CS, Albertson TA. Flumazenil for hypoactive delirium secondary to benzodiazepine exposure (FLYP Trial). 48th Critical Care Congress. San Diego, CA. Snapshot Theater Presentation. February 19, 2019.

Lee JA, Duby JJ, Cocanour CS. Effect of focused benzodiazepine use on length of stay in severe alcohol withdrawal syndrome. 47th Critical Care Congress. San Antonio, TX. Snapshot Theater Presentation. February 26, 2018.

Effect of fluid de-resuscitation on duration of mechanical ventilation in septic shock patients. 47th Critical Care Congress. San Antonio, TX. Snapshot Theater Presentation. February 26, 2018.

Bouajram RH, Sebat CM, Love D, Louie EL, Wilson MD, Duby JJ. Pain Assessment in Critically Ill Patients with Delirium: Self-reported Pain versus Behavioral Pain. 45th Critical Care Congress. Orlando, FL. Platform Presentation (and Star Achievement Award for Research). February 21, 2016.

Tasaka CL, Duby JJ, Pandya KA, Din C, Hardin KA. Use of Bispectral Index for Monitoring Sedation in Therapeutically Paralyzed Patients. 44th Critical Care Congress. Phoenix, Arizona. Display and Professor Walk Rounds. January 19, 2015.

Erin MC, Pandya KA, Sebat C, Tasaka CL, Duby JJ. Effect of Sodium and Fluid on Serum Sodium Levels in Patients with Intracranial Hypertension. 44th Critical Care Congress. Phoenix, Arizona. Display and Professor Walk Rounds. January 19, 2015.

Duby JJ, Poole PL, Cutler TW, Parker TL. Piloting P-ROC: Pharmacy Research Oversight Committee.
Purpose, Process, Performance. 2014 National Pharmacy Preceptors Conference. Washington, D.C. Poster Presentation. August 20 – 22, 2014.

Duby JJ, Berry AJ, Ghayyem P, Cocanour CS. Alcohol Withdrawal Syndrome in Critically Ill Patients: Protocolized vs Non-Protocolized Management. Annual Meeting. Western Trauma Association. Steamboat Springs, Colorado. Oral Presentation. March 2-7, 2014.

Firestone R, Duby JJ, Pandya K, Parker P. Effect of a conservative-correction DKA protocol on clinical outcomes in hospitalized patients. 43rd Critical Care Congress. San Francisco, CA: Professor Walk Rounds and Oral Presentation. January 11th, 2014.

Koo AY, Duby JJ. Angela Y Koo. Exploring the Diversity of Discourse and Voices in the Pharmacy Community: Authors, Speakers, and Terms. American Society of Health-System Pharmacist (ASHP) Midyear Clinical Meeting. Orlando, FL. December 8 – 12, 2013.

Evans CH, Duby JJ, Berry AJ, Schermer CR, Cocanour CS. Enteral albuterol decreases the need for chronotropic agents in patients with cervical spinal cord injury (CSCI) induced bradycardia. 72nd Annual Meeting, American Association for the Surgery of Trauma and Clinical Congress of Acute Care Surgery. San Francisco, CA: Podium Presentation. September 21, 2013.

Nagle E, Murthy M, Medina M, Floyd K, Love, D, Duby JJ. Nursing clinical discretion and decisions in the provision of pharmacotherapy in the intensive care unit. [abstract/poster]. 42nd Critical Care Congress. San Juan, Puerto Rico: Display and Professor Walk Rounds. January 20, 2012.

Bajorek S, Duby JJ, Heint S, Heintz H, Cocanour CS. Risk factors, prevalence, course, and complications of atrial fibrillation in critically ill trauma patients. 42nd Critical Care Congress. San Juan, Puerto Rico: Display and Professor Walk Rounds. January 20, 2013.

Murthy M, Nagle E, Parker P, Duby JJ. Dose-response effect of rescue intravenous dextrose for hypoglycemia in critically ill patients. 42nd Critical Care Congress. San Juan, Puerto Rico: Display and Oral Presentation. January 20, 2013.

Berry A, Cocanour CS, Duby JJ. Management of Alcohol Withdrawal Syndrome (AWS) that Complicates the Course of Critically Ill Patients. [abstract/poster]. 41st Critical Care Congress. Houston, TX: Display and Professor Walk Rounds. February 7, 2012.

Murthy M, Nagle E, Duby JJ, Roach D, Parker P. Dose Response to Rescue Intravenous Dextrose Administration following Hypoglycemic Events with an Insulin Infusion Protocol in Critically Ill Burn Patients. [abstract/poster]. 41st Critical Care Congress. Houston, TX: Display and Professor Walk Rounds. February 7, 2012.

Nagle E, Pretzlaff R, Duby JJ, Roberts JA, Murthy M, Dager WE. A Case Series Describing the Use of Bivalirudin in Pediatric Patients Maintained on Extracorporeal Life Support. [abstract/poster]. 41st Critical Care Congress. Houston, TX. February 4, 2012.

VonMuenster SJ, Cocanour CS, Duby JJ. Prevalence and Course of Atrial Fibrillation (AF) in Critically Ill Trauma Patients. [abstract/poster]. Annual Meeting. Western Surgical Association. Tucson, AZ: Podium Presentation, November 13, 2011.

Duby JJ, Rollins CJ. Survey of nurse administration of phenytoin through enteral feeding tubes concomitantly with enteral nutrition. Poster: ASHP Summer Meeting and Exhibition. San Francisco, CA. June 25, 2007.

Duby JJ, Erstad BL, Abarca J, Camamo JM, Huckleberry Y, Bramblett SN. Cost-Benefit of Epoetin alfa in the Critically Ill Patient: Published Trials versus Practice. ASHP 2006 Summer Meeting and Exhibition. Orlando, FA. June 28, 2006.

National

• Not Just a Fairy Godmother: February 19, 2020
Mentoring in the Millennial Generation Annual Congress.
Moderator Society of Critical Care Medicine.

• Star Research Presentations: Resuscitation February 16, 2020
Moderator Annual Congress.
Society of Critical Care Medicine.

• Rocking Residency Research March 19, 2019
Speaker Pacific Coast Preceptor Conference
CSHP Napa, CA

• Bedside Pharmacologic Management February 16, 2019
Coordinator and Moderator Bedside Pharmacological Management. Pre-Congress Symposium. Society of Critical Care Medicine.

• Focusing Fire or Watchful Waiting: February 16, 2019
Substance Withdrawal in the ICU. Bedside Pharmacological
Speaker Management. Pre-Congress Symposium. Society of Critical Care Medicine.

• Understanding and Navigating the February 17, 2019
Realities of Drug Shortages in the ICU Annual Congress.
Roundtable Topic Discussion. Society of Critical Care Medicine.
Facilitator. San Diego, CA

• Research Snapshot Theater: Endocrine II. February 18, 2019
Moderator Annual Congress.
Society of Critical Care Medicine.
San Diego, CA

• How We Miss Withdrawal in the ICU. February 19, 2019
Speaker. Annual Congress.
Society of Critical Care Medicine.
San Diego, CA

• Rocking Residency Research October 13, 2018
Speaker National Pharmacy Preceptors
Conference
ASHP Washington, DC

• Managing Critical Burns: Pharmacotherapy February 27, 2018
and Withdrawal Society of Critical Care Medicine
Speaker 47th Critical Care Congress. San Antonio, TX.

• Snapshot Theater: Infectious Disease February 26, 2018
Moderator. Society of Critical Care Medicine
47th Critical Care Congress. San Antonio, TX.


• Rocking Residency Research August 18, 2017
Speaker National Pharmacy Preceptors
Conference.
ASHP
Washington, DC

• Society of Critical Care Medicine February 17, 2017.
Journal Club Webcast.
Moderator.

• Research Snapshot Theater: Surgery, January 22, 2017.
Trauma, Burns. Society of Critical Care Medicine
Moderator. 46th Critical Care Congress.
Honolulu, HI.

• Research Snapshot Theater: Endocrine. February 23, 2016.
Moderator. Society of Critical Care Medicine
45th Critical Care Congress.
Orlando, FL

• What Type of Pharmacist are YOU? October 11, 2015.
“The Medicinal Therapist.” 13th Annual UC Davis Pre-Pharmacy
Presentation and Workshop Session. & Pre-Health
Professions National Conference.
University of California, Davis.
Davis, CA.

• Resuscitation for Shock Syndromes January 19, 2015
Speaker. Society of Critical Care Medicine
44th Critical Care Congress,
Phoenix, AZ

• Professor Walk Rounds January 19, 2015
Poster moderator. Society of Critical Care Medicine
44th Critical Care Congress
Phoenix, AZ

• Implementing the PAD Guidelines: December 10, 2013
Pharmacist's Role Within & Beyond the ICU ASHP
Continuing Education. Midyear Clinical Meeting.
Orlando, FL.

• What Type of Pharmacist are YOU? October 13, 2013.
“The Medicinal Therapist.” 11th Annual UC Davis Pre-Pharmacy & Pre-Health
Presentation and Workshop Session. Professions National Conference.
University of California, Davis. Davis, CA.

• Journal Club Webcast. May 18, 2012.
Moderator. Clinical Pharmacy and Pharmacology Section.
Society of Critical Care Medicine.

• Journal Club . November 18, 2011.
Moderator. Clinical Pharmacy and Pharmacology Section. Society of Critical Care Medicine.

• Sedation in the ICU: Special Tools and Tactics. October 17, 2009.
Continuing Education. Advanced Critical Care and Trauma
Conference. Contemporary Forums. San Francisco.

• Pain Management in the ICU. October 17, 2009.
Continuing Education. Advanced Critical Care and Trauma Conference. Contemporary Forums. San Francisco.

• Painful Diabetic Neuropathy: September 25, 2008.
Evidenced-Based Treatment. Teleconference to Greater NY Health Association. 170 acute and long-term care institution.


State

• Rocking Residency Research March 29, 2019
Speaker Pacific Coast Preceptor Conference
Conference
CSHP Napa, CA.

• ICU Liberation for the Pharmacist. October 29, 2016.
Moderator. California Society of Health-System Pharmacist Seminar. Anaheim, CA.

• Reading with Purpose: High Impact Interventions October 28, 2016.
from the Med List. California Society of Health-System Pharmacist Seminar. Anaheim, CA.
Speaker.

• Critical Care Workshop: Applying Emerging October 28, 2016
Evidence and Essential Skills to Common California Society of Health-System Conundrums Seminar. Anaheim, CA.
Pharmacist
Speaker.

• Vancomycin Continuous Infusions: October 10, 2015.
Why & How from 0 – 250 ml/min. California Society of Health-System Pharmacists Speaker. Seminar. San Francisco, CA.

• Guideline Implementation: October 10, 2015.
Bridging Evidence, Education, Execution. California Society of Health-System Pharmacists Continuing Education. Seminar. San Francisco, CA.

• Residency Strategies: October 31, 2014
Deciding What You Want...Then Getting It! California Society of Health-System Pharmacists Continuing Education. Seminar. San Francisco, CA.

• Alcohol Withdrawal Syndrome: October 31, 2014
Special Tools and Tactics California Society of Health-System Pharmacists Continuing Education. Seminar. San Francisco, CA.

• Nurses vs. Pharmacists: October 21, 2012
Misconceptions and Miscommunications. California Society of Health-System Pharmacists Continuing Education. Seminar. Las Vegas, NV.

• Delirium in the ICU: October 21, 2012
Pharmacological Prophylaxis and Treatment. California Society of Health-System Pharmacists Continuing Education. Seminar. Las Vegas, NV.

• Alcohol Withdrawal Syndrome: On a Scale of 9 to 10. November 4, 2011.
Continuing Education. California Society of Health-System Pharmacists Seminar. Anaheim, CA.

• Roundtable Program for Students and Residents. November 4, 2011.
Presentation and Workshop. California Society of Health-System Pharmacists Seminar. San Francisco, CA.

• Severe Sepsis and Septic Shock Revisited. October 3, 2009.
Continuing Education. California Society of Health-System Pharmacists, Seminar. San Diego.

Firestone RL, Parker PL, Pandya KA, Wilson MD, Duby JJ. Moderate-Intensity Insulin Therapy Is Associated With Reduced Length of Stay in Critically Ill Patients With Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State. Crit Care Med. 2019 May;47(5):700-705.

Publications:
Cutler TW, Chuang A, Huynh TD, Witt RG, Branch J, Pon T, White R. A retrospective descriptive analysis of patient adherence to dabigatran at a large academic medical center. J Manag Care Pharm. 2014 Oct; 20(10):1028-34. PMID: 25278325

Pon TK, Dager WE, Roberts AJ, White RH. Subcutaneous enoxaparin for therapeutic anticoagulation in hemodialysis patients. Thromb Res. 2014 Jun; 133(6):1023-8. PMID: 24718051

Burton J, Pon T. SB 493: Making the Case to Healthcare Practitioners. California Pharmacist 2015;62:17-20.

Dager WE, Tsu LV, Pon TK. Considerations for Systemic Anticoagulation in ESRD. Semin Dial. 2015 Jul; 28(4):354-62. PMID: 25951901

Phillips HJ, Dangler A, Klem PM, Chu F, Pon T, Liewer S, Thompson Bastin ML, Halfpap JJ, Fish J, Stun L, Varughese CA. Preceptor development: Responses to frequently asked questions from preceptors in academic hospitals. Am J Health Syst Pharm. 2016 May 1; 73(9):e261-6. PMID: 27099334

Pon TK, Mahajan A, Rosenberg A, Amin A, Shah D, Jenkins I, Gupta V, Hofmann H, Bejjani A, White R. Platelet response to direct thrombin inhibitor or fondaparinux treatment in patients with suspected heparin-induced thrombocytopenia. J Thromb Thrombolysis. 2018 Mar 24. PMID: 29574610.

Pon TK, Wessel N, Cagonot V, Delmonte R, Roach D, Finta L. Utilization of venous thromboembolism prophylaxis in American hospitalized pregnant women undergoing cesarean section. Int J Clin Pharm. 2019 Jan 19. PMID: 30661217

Pon T, Shin J (2018). Bleeding Disorders. In: Tisdale JE, Miller DA (Eds). Drug-Induced Diseases: Prevention, Detection, and Management (1025-1048). Bethesda, MD: ASHP.

Posters:
Evaluation of therapeutic anticoagulation with enoxaparin in hemodialysis (ACCP Annual Meeting, Albuquerque, NM, 2013)
Acute heart failure admission from skilled nursing facilities versus community: an evaluation of mortality risk and other clinical outcomes (ASHP Midyear Clinical Meeting, New Orleans, LA, 2015)
Assessing the appropriateness of venous thromboembolism prophylaxis and clinical consequences of over-prophylaxis in low-risk patients and moderate- or high-risk patients with exceptions to chemical prophylaxis (ASHP Midyear Clinical Meeting, New Orleans, LA, 2015)
Evaluation of appropriate venous thromboembolism (VTE) prophylaxis in hospitalized pregnant women undergoing cesarean section (ASHP Midyear Clinical Meeting, New Orleans, LA, 2015)
Time to restart anticoagulation in patients with major bleed (TRAP-Bleed) (ASHP Midyear Clinical Meeting, Las Vegas, NV, 2016)
An interactive instructional video to improve interprofessional education and teamwork (AACP Annual Meeting, Nashville, TN, 2017)
Initiation of linezolid orally versus vancomycin as empiric treatment for likely acute MRSA pneumonia (ILOVELAMP) (ASHP Midyear Clinical Meeting, Orlando, FL, 2018)
Impact of general medicine pharmacist interventions on medication errors and discharge transitions of care activities (UC Davis Medical Center Healthcare Quality Forum, Sacramento, CA, 2018)

Updates in Pharmacotherapy: Cardiology, Diabetes, and Community-Acquired Infections (Indian Health Services California Best Practices and GPRA Measures Conference, Sacramento, CA, 2013)

Updates in Pulmonary Arterial Hypertension: Combination PAH Therapy - When is it Appropriate? (ASHP Midyear Clinical Meeting, Anaheim, CA, 2014)

Formalizing Preceptor Training: Is it time for a Preceptor Teaching Certificate (AACP Annual Meeting, Anaheim, CA, 2016)

Implementation of a master preceptor program (CSHP West Coast Preceptor Conference, Asilomar, CA, 2018)

Difficult times in precepting: navigating challenging situations (CSHP West Coast Preceptor Conference, Asilomar, CA, 2018)

Talkin' 'bout my generation: teaching a new age of learners (CSHP Pacific Coast Preceptor Conference, Napa, CA, 2019)

Cancer-associated thrombosis: considerations for prevention and treatment of the role of DOACs (2019 APP Oncology Summit, San Francisco, 2019)

Updates in Anticoagulation: The New, The Old, and The Grey (CSHP Seminar, Anaheim, CA, 2019)

1. 2019 Pon TK, Wessel N, Cagonot V, Delmonte R, Roach DM, and Finta L. Utilization of venous thromboembolism prophylaxis in American hospitalized pregnant women undergoing cesarean section. Int J Clin Pharm. 2019 Feb; 41(1): 264-271.

2. 2018 Bibera M, Alnimri M, Brown J, Hao D, Le K, Rieland A, Roach DM, and Zhu E. The Rate of Cytomegalovirus Infections and Disease in Renal Transplant Patients. Poster presented (Bibera) at the American Society of Nephrology (ASN) Kidney Week. San Diego, CA. (October).

3. 2018 Kyu A, Tran K, Ali S, Le K, Pon T, Roach DM, Bajorek S, and Serna M. Impact of the General Medicine Pharmacist Interventions on Medication Errors and Discharge Transitions of Care Activities. Poster presented (Kyu, Tran, and Ali) at the 8th Annual UC Davis Healthcare Quality Forum. Sacramento, CA. (March).

4. 2018 Cua J, Takamura K, Pon T, Roach DM, Serna M, Le K, and Zhu E. Initiation of Linezolid Orally versus Vancomycin for Empiric Treatment for Likely Acute MRSA Pneumonia (ILOVELAMP). UCSF School of Pharmacy CP150 Project. February. (Report).

5. 2017 Zhu E and Roach DM. Point Prevalency Study of the Effect of Antibiotic Timeouts on Antibiotic Utilization. Pharmacy Network Research Committee. Vizient – University Health System Consortium. September. (National Stewardship Study Participant). -Publications-

6. 2017 Vu C, Moghadam G, Le K, Serna M, and Roach DM. Evaluation of Proton Pump Inhibitor Continuation at Discharge. UCSF School of Pharmacy CP150 Project. March. (Report).

7. 2017 Chen I, Lau K, Truong L, Nguyen N, Le K, Serna M, and Roach DM. Inappropriate Proton Pump Inhibitor Initiation for Stress Ulcer Prophylaxis. UCSF School of Pharmacy CP150 Project. March. (Report).

8. 2017 Cua J, Takamura K, Pon T, Roach DM, Serna M, Le K, and Zhu E. Initiation of Linezolid Orally versus Vancomycin for Empiric Treatment of Likely Acute MRSA Pneumonia (ILOVELAMP). Poster presented (Cua and Takamura) at the 52nd Midyear Clinical Meeting of the American Society of Health-System Pharmacists. Orlando, FL. (December).

9. 2017 Chen I, Lau K, Moghadam G, Nguyen T, Truong L, Vu C, Le K, Serna M, and Roach DM. Evaluation of Proton Pump Inhibitor Initiation and Continuation at Discharge at UC Davis Medical Center. Poster presented at the 7th Annual UC Davis Healthcare Quality Forum. Sacramento, CA. (March).

10. 2016 Cagonot V, Delmonte R, Wessel N, Roach DM, and Pon, T. Evaluation of appropriate venous thromboembolism (VTE) prophylaxis in hospitalized pregnant women undergoing cesarean section. Poster presented (Wessel N) at the 6th Annual UC Davis Healthcare Quality Forum. Sacramento, CA. (March).

11. 2015 Nagle E, Murthy M, Duby J, Parker P, Durbin-Johnson B, and Roach DM. Blood Glucose Response to Rescue Dextrose in Hypoglycemic, Critically Ill Patients Receiving an Insulin Infusion. Ann Pharmacother. 2015 May; 49(8): 892-6.

12. 2015 Cagonot V, Delmonte R, Wessel N, Roach DM, and Pon, T. Evaluation of appropriate venous thromboembolism (VTE) prophylaxis in hospitalized pregnant women undergoing cesarean section. Poster presented (Cagonot and Delmonte) at the 50th Midyear Clinical Meeting of the American Society of Health-System Pharmacists. New Orleans, LA. (December).

13. 2010 Nagle E, Parker P, Duby J, and Roach DM. Evaluation of the Dose Response to Rescue Intravenous Dextrose Administration following Hypoglycemic Events with an Insulin Infusion Protocol in Critically Ill Burn Patients. University HealthSystem Consortium Resident Poster presented (Nagle E) at the 45th Midyear Clinical Meeting at the American Society of Health-System Pharmacists. Anaheim, California. (December).

1. 2018 Bibera M, Alnimri M, Brown J, Hao D, Le K, Rieland A, Roach DM, and Zhu E. Rate of Cytomegalovirus Infections and Disease in Renal Transplant Patients. Presented (Bibera) at the 1st Annual UC Collaborative Annual Pharmacy Leadership Forum, Davis, CA. (June).

Stoianovici R, Adams CD, Brunetti L. Comparison of melatonin and zolpidem for sleep in an academic community hospital: an analysis of patient perception and inpatient outcomes. J Pharm Pract. 2019 Jun. [Epub]

Narayanan N, Adams CD, Kubiak DW, Cheng S, Stoianovici R, Kagan L, Brunetti L. Evaluation of treatment options for methicillin-resistant Staphylococcus aureus infections in the obese patient. Infect Drug Resist. 2019;12:877-891.

Stoianovici R, Zadikian N, Strand A, Greene C, McMillian W. Hypertonic sodium chloride versus combination hypertonic sodium chloride and sodium acetate in patients with traumatic brain injury.
Presented at the Vizient University Health System Consortium Pharmacy Resident Poster Session (109b); 2016 Dec; Las Vegas, NV and 48th Society of Critical Care Medicine Critical Care Congress; 2019 Feb; San Diego, CA.

Build a Juggernaut Opioid Stewardship Team to Stomp Out Adverse Events, Power Huddle Presentation, The Art of Care, 2019 Vizient Connections Education Summit. September 18, 2019. Las Vegas, Nevada.

Asmuth DM, Chen AY, Utay NS, Torok N, Poole PL, Vongspanich J, Haight KR, Sumasunderam AD, Byambaa E, Li X-D, Cohen ST, Berglund L, Holodniy M, Michalak TI. Impact of Occult HCV Infection (OCI) on Systemic Immune Activation after DAA Therapy. In Abstracts for the 25rd Conference on Retroviruses and Opportunistic Infections. Boston MA, USA, March 4-7, 2018. Abstract 636.

Yu, Michelle, Nguyen, J, Dray, J. Analysis of Clinical Outcomes Associated with Generic-to-Generic Interchange of Tacrolimus in Renal Transplantation. Presented at ACCP 2019.

Mitchell Y, Volpendesta J, Wilson M, Dray J. Evaluation of efficiency and patient perception of transplant medication education after pharmacist created education video. Presented at Healthcare Con and American Transplant Congress 2018.

Hluhanich R, Vongspanich J, Poole P, Wilson M. Management of Hypertensive HIV-positive Patients in a Patient-Centered Medical Home. Presented at IDSA and ACCP 2014.

Young S, Louie EL, Palmieri T, Duby J, Effect of a Bundled Approach on Procedural Pain Control in Burn Patients. Poster Presentation at American Burn Association (ABA) Conference; April 2019; Las Vegas NV.

Young S, Duby J, Louie EL, Palmieri T, Impact of Multimodal Analgesia on Opioid Requirements in Critically Ill Burn Patients. Accepted platform presentation at American Burn Association (ABA) Conference, March 2020; Orlando Florida.